drugset / Trial / NCT06444737

Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia

NCT06444737

Unknown 300 enrolled Mongi Slim Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

A prospective, bicentric, randomized, double-blind controlled study including parturients scheduled for elective caesarean delivery under spinal anaesthesia and randomized and assigned to one of the two groups: Group O ondansetron : receiving Intravenous (IV) ondansetron 0.10 mg/ kg diluted in 5 ml normal saline, 5 min before spinal anesthesia Group C control : receiving IV normal saline 5 ml (control group) 5 min before spinal anesthesia OBJECTIVE : To evaluate the efficacy of ondansetron in preventing post-dural puncture headache after spinal anaesthesia for caesarean section.

Timeline

Start
2023-11-30
Primary completion
2024-06-30
Completion
2024-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 0.1 mg/kg Intravenous